Global Oseltamivir Market Growth 2022-2028
- LP 4725033
- 74 Pages
- January 2022
- Pharmaceuticals
The United States Oseltamivir market is expected at value of US$ million in 2021 and grow at approximately % CAGR during review period. China constitutes a % market for the global Oseltamivir market, reaching US$ million by the year 2028. As for the Europe Oseltamivir landscape, Germany is projected to reach US$ million by 2028 trailing a CAGR of % over the forecast period. In APAC, the growth rates of other notable markets (Japan and South Korea) are projected to be at % and % respectively for the next 5-year period.
Global main Oseltamivir players cover Roche, , , and , etc. In terms of revenue, the global largest two companies occupy a share nearly % in 2021.
This report presents a comprehensive overview, market shares, and growth opportunities of Oseltamivir market by product type, application, key manufacturers and key regions and countries.
Segmentation by type: breakdown data from 2017 to 2022, in Section 2.3; and forecast to 2028 in section 12.6
Capsule
Oral Solution
Segmentation by application: breakdown data from 2017 to 2022, in Section 2.4; and forecast to 2028 in section 12.7.
Influenza A
Influenza B
This report also splits the market by region: Breakdown data in Chapter 4, 5, 6, 7 and 8.
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The report also presents the market competition landscape and a corresponding detailed analysis of the prominent manufacturers in this market, include
Roche
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
2 Executive Summary
2.1 World Market Overview
2.1.1 Global Oseltamivir Annual Sales 2017-2028
2.1.2 World Current & Future Analysis for Oseltamivir by Geographic Region, 2017, 2022 & 2028
2.1.3 World Current & Future Analysis for Oseltamivir by Country/Region, 2017, 2022 & 2028
2.2 Oseltamivir Segment by Type
2.2.1 Capsule
2.2.2 Oral Solution
2.3 Oseltamivir Sales by Type
2.3.1 Global Oseltamivir Sales Market Share by Type (2017-2022)
2.3.2 Global Oseltamivir Revenue and Market Share by Type (2017-2022)
2.3.3 Global Oseltamivir Sale Price by Type (2017-2022)
2.4 Oseltamivir Segment by Application
2.4.1 Influenza A
2.4.2 Influenza B
2.5 Oseltamivir Sales by Application
2.5.1 Global Oseltamivir Sale Market Share by Application (2017-2022)
2.5.2 Global Oseltamivir Revenue and Market Share by Application (2017-2022)
2.5.3 Global Oseltamivir Sale Price by Application (2017-2022)
3 Global Oseltamivir by Company
3.1 Global Oseltamivir Breakdown Data by Company
3.1.1 Global Oseltamivir Annual Sales by Company (2020-2022)
3.1.2 Global Oseltamivir Sales Market Share by Company (2020-2022)
3.2 Global Oseltamivir Annual Revenue by Company (2020-2022)
3.2.1 Global Oseltamivir Revenue by Company (2020-2022)
3.2.2 Global Oseltamivir Revenue Market Share by Company (2020-2022)
3.3 Global Oseltamivir Sale Price by Company
3.4 Key Manufacturers Oseltamivir Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Oseltamivir Product Location Distribution
3.4.2 Players Oseltamivir Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)
3.6 New Products and Potential Entrants
3.7 Mergers & Acquisitions, Expansion
4 World Historic Review for Oseltamivir by Geographic Region
4.1 World Historic Oseltamivir Market Size by Geographic Region (2017-2022)
4.1.1 Global Oseltamivir Annual Sales by Geographic Region (2017-2022)
4.1.2 Global Oseltamivir Annual Revenue by Geographic Region
4.2 World Historic Oseltamivir Market Size by Country/Region (2017-2022)
4.2.1 Global Oseltamivir Annual Sales by Country/Region (2017-2022)
4.2.2 Global Oseltamivir Annual Revenue by Country/Region
4.3 Americas Oseltamivir Sales Growth
4.4 APAC Oseltamivir Sales Growth
4.5 Europe Oseltamivir Sales Growth
4.6 Middle East & Africa Oseltamivir Sales Growth
5 Americas
5.1 Americas Oseltamivir Sales by Country
5.1.1 Americas Oseltamivir Sales by Country (2017-2022)
5.1.2 Americas Oseltamivir Revenue by Country (2017-2022)
5.2 Americas Oseltamivir Sales by Type
5.3 Americas Oseltamivir Sales by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Oseltamivir Sales by Region
6.1.1 APAC Oseltamivir Sales by Region (2017-2022)
6.1.2 APAC Oseltamivir Revenue by Region (2017-2022)
6.2 APAC Oseltamivir Sales by Type
6.3 APAC Oseltamivir Sales by Application
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 Europe
7.1 Europe Oseltamivir by Country
7.1.1 Europe Oseltamivir Sales by Country (2017-2022)
7.1.2 Europe Oseltamivir Revenue by Country (2017-2022)
7.2 Europe Oseltamivir Sales by Type
7.3 Europe Oseltamivir Sales by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 Middle East & Africa
8.1 Middle East & Africa Oseltamivir by Country
8.1.1 Middle East & Africa Oseltamivir Sales by Country (2017-2022)
8.1.2 Middle East & Africa Oseltamivir Revenue by Country (2017-2022)
8.2 Middle East & Africa Oseltamivir Sales by Type
8.3 Middle East & Africa Oseltamivir Sales by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 Market Drivers, Challenges and Trends
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 Manufacturing Cost Structure Analysis
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Oseltamivir
10.3 Manufacturing Process Analysis of Oseltamivir
10.4 Industry Chain Structure of Oseltamivir
11 Marketing, Distributors and Customer
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Oseltamivir Distributors
11.3 Oseltamivir Customer
12 World Forecast Review for Oseltamivir by Geographic Region
12.1 Global Oseltamivir Market Size Forecast by Region
12.1.1 Global Oseltamivir Forecast by Region (2023-2028)
12.1.2 Global Oseltamivir Annual Revenue Forecast by Region (2023-2028)
12.2 Americas Forecast by Country
12.3 APAC Forecast by Region
12.4 Europe Forecast by Country
12.5 Middle East & Africa Forecast by Country
12.6 Global Oseltamivir Forecast by Type
12.7 Global Oseltamivir Forecast by Application
13 Key Players Analysis
13.1 Roche
13.1.1 Roche Company Information
13.1.2 Roche Oseltamivir Product Offered
13.1.3 Roche Oseltamivir Sales, Revenue, Price and Gross Margin (2020-2022)
13.1.4 Roche Main Business Overview
13.1.5 Roche Latest Developments
14 Research Findings and Conclusion
Table 1. Oseltamivir Annual Sales CAGR by Geographic Region (2017, 2022 & 2028) & ($ millions)
Table 2. Oseltamivir Annual Sales CAGR by Country/Region (2017, 2022 & 2028) & ($ millions)
Table 3. Major Players of Capsule
Table 4. Major Players of Oral Solution
Table 5. Global Oseltamivir Sales by Type (2017-2022) & (K Units)
Table 6. Global Oseltamivir Sales Market Share by Type (2017-2022)
Table 7. Global Oseltamivir Revenue by Type (2017-2022) & ($ million)
Table 8. Global Oseltamivir Revenue Market Share by Type (2017-2022)
Table 9. Global Oseltamivir Sale Price by Type (2017-2022) & (USD/Unit)
Table 10. Global Oseltamivir Sales by Application (2017-2022) & (K Units)
Table 11. Global Oseltamivir Sales Market Share by Application (2017-2022)
Table 12. Global Oseltamivir Revenue by Application (2017-2022)
Table 13. Global Oseltamivir Revenue Market Share by Application (2017-2022)
Table 14. Global Oseltamivir Sale Price by Application (2017-2022) & (USD/Unit)
Table 15. Global Oseltamivir Sales by Company (2020-2022) & (K Units)
Table 16. Global Oseltamivir Sales Market Share by Company (2020-2022)
Table 17. Global Oseltamivir Revenue by Company (2020-2022) ($ Millions)
Table 18. Global Oseltamivir Revenue Market Share by Company (2020-2022)
Table 19. Global Oseltamivir Sale Price by Company (2020-2022) & (USD/Unit)
Table 20. Key Manufacturers Oseltamivir Producing Area Distribution and Sales Area
Table 21. Players Oseltamivir Products Offered
Table 22. Oseltamivir Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)
Table 23. New Products and Potential Entrants
Table 24. Mergers & Acquisitions, Expansion
Table 25. Global Oseltamivir Sales by Geographic Region (2017-2022) & (K Units)
Table 26. Global Oseltamivir Sales Market Share Geographic Region (2017-2022)
Table 27. Global Oseltamivir Revenue by Geographic Region (2017-2022) & ($ millions)
Table 28. Global Oseltamivir Revenue Market Share by Geographic Region (2017-2022)
Table 29. Global Oseltamivir Sales by Country/Region (2017-2022) & (K Units)
Table 30. Global Oseltamivir Sales Market Share by Country/Region (2017-2022)
Table 31. Global Oseltamivir Revenue by Country/Region (2017-2022) & ($ millions)
Table 32. Global Oseltamivir Revenue Market Share by Country/Region (2017-2022)
Table 33. Americas Oseltamivir Sales by Country (2017-2022) & (K Units)
Table 34. Americas Oseltamivir Sales Market Share by Country (2017-2022)
Table 35. Americas Oseltamivir Revenue by Country (2017-2022) & ($ Millions)
Table 36. Americas Oseltamivir Revenue Market Share by Country (2017-2022)
Table 37. Americas Oseltamivir Sales by Type (2017-2022) & (K Units)
Table 38. Americas Oseltamivir Sales Market Share by Type (2017-2022)
Table 39. Americas Oseltamivir Sales by Application (2017-2022) & (K Units)
Table 40. Americas Oseltamivir Sales Market Share by Application (2017-2022)
Table 41. APAC Oseltamivir Sales by Region (2017-2022) & (K Units)
Table 42. APAC Oseltamivir Sales Market Share by Region (2017-2022)
Table 43. APAC Oseltamivir Revenue by Region (2017-2022) & ($ Millions)
Table 44. APAC Oseltamivir Revenue Market Share by Region (2017-2022)
Table 45. APAC Oseltamivir Sales by Type (2017-2022) & (K Units)
Table 46. APAC Oseltamivir Sales Market Share by Type (2017-2022)
Table 47. APAC Oseltamivir Sales by Application (2017-2022) & (K Units)
Table 48. APAC Oseltamivir Sales Market Share by Application (2017-2022)
Table 49. Europe Oseltamivir Sales by Country (2017-2022) & (K Units)
Table 50. Europe Oseltamivir Sales Market Share by Country (2017-2022)
Table 51. Europe Oseltamivir Revenue by Country (2017-2022) & ($ Millions)
Table 52. Europe Oseltamivir Revenue Market Share by Country (2017-2022)
Table 53. Europe Oseltamivir Sales by Type (2017-2022) & (K Units)
Table 54. Europe Oseltamivir Sales Market Share by Type (2017-2022)
Table 55. Europe Oseltamivir Sales by Application (2017-2022) & (K Units)
Table 56. Europe Oseltamivir Sales Market Share by Application (2017-2022)
Table 57. Middle East & Africa Oseltamivir Sales by Country (2017-2022) & (K Units)
Table 58. Middle East & Africa Oseltamivir Sales Market Share by Country (2017-2022)
Table 59. Middle East & Africa Oseltamivir Revenue by Country (2017-2022) & ($ Millions)
Table 60. Middle East & Africa Oseltamivir Revenue Market Share by Country (2017-2022)
Table 61. Middle East & Africa Oseltamivir Sales by Type (2017-2022) & (K Units)
Table 62. Middle East & Africa Oseltamivir Sales Market Share by Type (2017-2022)
Table 63. Middle East & Africa Oseltamivir Sales by Application (2017-2022) & (K Units)
Table 64. Middle East & Africa Oseltamivir Sales Market Share by Application (2017-2022)
Table 65. Key Market Drivers & Growth Opportunities of Oseltamivir
Table 66. Key Market Challenges & Risks of Oseltamivir
Table 67. Key Industry Trends of Oseltamivir
Table 68. Oseltamivir Raw Material
Table 69. Key Suppliers of Raw Materials
Table 70. Oseltamivir Distributors List
Table 71. Oseltamivir Customer List
Table 72. Global Oseltamivir Sales Forecast by Region (2023-2028) & (K Units)
Table 73. Global Oseltamivir Sales Market Forecast by Region
Table 74. Global Oseltamivir Revenue Forecast by Region (2023-2028) & ($ millions)
Table 75. Global Oseltamivir Revenue Market Share Forecast by Region (2023-2028)
Table 76. Americas Oseltamivir Sales Forecast by Country (2023-2028) & (K Units)
Table 77. Americas Oseltamivir Revenue Forecast by Country (2023-2028) & ($ millions)
Table 78. APAC Oseltamivir Sales Forecast by Region (2023-2028) & (K Units)
Table 79. APAC Oseltamivir Revenue Forecast by Region (2023-2028) & ($ millions)
Table 80. Europe Oseltamivir Sales Forecast by Country (2023-2028) & (K Units)
Table 81. Europe Oseltamivir Revenue Forecast by Country (2023-2028) & ($ millions)
Table 82. Middle East & Africa Oseltamivir Sales Forecast by Country (2023-2028) & (K Units)
Table 83. Middle East & Africa Oseltamivir Revenue Forecast by Country (2023-2028) & ($ millions)
Table 84. Global Oseltamivir Sales Forecast by Type (2023-2028) & (K Units)
Table 85. Global Oseltamivir Sales Market Share Forecast by Type (2023-2028)
Table 86. Global Oseltamivir Revenue Forecast by Type (2023-2028) & ($ Millions)
Table 87. Global Oseltamivir Revenue Market Share Forecast by Type (2023-2028)
Table 88. Global Oseltamivir Sales Forecast by Application (2023-2028) & (K Units)
Table 89. Global Oseltamivir Sales Market Share Forecast by Application (2023-2028)
Table 90. Global Oseltamivir Revenue Forecast by Application (2023-2028) & ($ Millions)
Table 91. Global Oseltamivir Revenue Market Share Forecast by Application (2023-2028)
Table 92. Roche Basic Information, Oseltamivir Manufacturing Base, Sales Area and Its Competitors
Table 93. Roche Oseltamivir Product Offered
Table 94. Roche Oseltamivir Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2022)
Table 95. Roche Main Business
Table 96. Roche Latest Developments
List of Figures
Figure 1. Picture of Oseltamivir
Figure 2. Oseltamivir Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Oseltamivir Sales Growth Rate 2017-2028 (K Units)
Figure 7. Global Oseltamivir Revenue Growth Rate 2017-2028 ($ Millions)
Figure 8. Oseltamivir Sales by Region (2021 & 2028) & ($ millions)
Figure 9. Product Picture of Capsule
Figure 10. Product Picture of Oral Solution
Figure 11. Global Oseltamivir Sales Market Share by Type in 2021
Figure 12. Global Oseltamivir Revenue Market Share by Type (2017-2022)
Figure 13. Oseltamivir Consumed in Influenza A
Figure 14. Global Oseltamivir Market: Influenza A (2017-2022) & (K Units)
Figure 15. Oseltamivir Consumed in Influenza B
Figure 16. Global Oseltamivir Market: Influenza B (2017-2022) & (K Units)
Figure 17. Global Oseltamivir Sales Market Share by Application (2017-2022)
Figure 18. Global Oseltamivir Revenue Market Share by Application in 2021
Figure 19. Oseltamivir Revenue Market by Company in 2021 ($ Million)
Figure 20. Global Oseltamivir Revenue Market Share by Company in 2021
Figure 21. Global Oseltamivir Sales Market Share by Geographic Region (2017-2022)
Figure 22. Global Oseltamivir Revenue Market Share by Geographic Region in 2021
Figure 23. Global Oseltamivir Sales Market Share by Region (2017-2022)
Figure 24. Global Oseltamivir Revenue Market Share by Country/Region in 2021
Figure 25. Americas Oseltamivir Sales 2017-2022 (K Units)
Figure 26. Americas Oseltamivir Revenue 2017-2022 ($ Millions)
Figure 27. APAC Oseltamivir Sales 2017-2022 (K Units)
Figure 28. APAC Oseltamivir Revenue 2017-2022 ($ Millions)
Figure 29. Europe Oseltamivir Sales 2017-2022 (K Units)
Figure 30. Europe Oseltamivir Revenue 2017-2022 ($ Millions)
Figure 31. Middle East & Africa Oseltamivir Sales 2017-2022 (K Units)
Figure 32. Middle East & Africa Oseltamivir Revenue 2017-2022 ($ Millions)
Figure 33. Americas Oseltamivir Sales Market Share by Country in 2021
Figure 34. Americas Oseltamivir Revenue Market Share by Country in 2021
Figure 35. United States Oseltamivir Revenue Growth 2017-2022 ($ Millions)
Figure 36. Canada Oseltamivir Revenue Growth 2017-2022 ($ Millions)
Figure 37. Mexico Oseltamivir Revenue Growth 2017-2022 ($ Millions)
Figure 38. Brazil Oseltamivir Revenue Growth 2017-2022 ($ Millions)
Figure 39. APAC Oseltamivir Sales Market Share by Region in 2021
Figure 40. APAC Oseltamivir Revenue Market Share by Regions in 2021
Figure 41. China Oseltamivir Revenue Growth 2017-2022 ($ Millions)
Figure 42. Japan Oseltamivir Revenue Growth 2017-2022 ($ Millions)
Figure 43. South Korea Oseltamivir Revenue Growth 2017-2022 ($ Millions)
Figure 44. Southeast Asia Oseltamivir Revenue Growth 2017-2022 ($ Millions)
Figure 45. India Oseltamivir Revenue Growth 2017-2022 ($ Millions)
Figure 46. Australia Oseltamivir Revenue Growth 2017-2022 ($ Millions)
Figure 47. Europe Oseltamivir Sales Market Share by Country in 2021
Figure 48. Europe Oseltamivir Revenue Market Share by Country in 2021
Figure 49. Germany Oseltamivir Revenue Growth 2017-2022 ($ Millions)
Figure 50. France Oseltamivir Revenue Growth 2017-2022 ($ Millions)
Figure 51. UK Oseltamivir Revenue Growth 2017-2022 ($ Millions)
Figure 52. Italy Oseltamivir Revenue Growth 2017-2022 ($ Millions)
Figure 53. Russia Oseltamivir Revenue Growth 2017-2022 ($ Millions)
Figure 54. Middle East & Africa Oseltamivir Sales Market Share by Country in 2021
Figure 55. Middle East & Africa Oseltamivir Revenue Market Share by Country in 2021
Figure 56. Egypt Oseltamivir Revenue Growth 2017-2022 ($ Millions)
Figure 57. South Africa Oseltamivir Revenue Growth 2017-2022 ($ Millions)
Figure 58. Israel Oseltamivir Revenue Growth 2017-2022 ($ Millions)
Figure 59. Turkey Oseltamivir Revenue Growth 2017-2022 ($ Millions)
Figure 60. GCC Country Oseltamivir Revenue Growth 2017-2022 ($ Millions)
Figure 61. Manufacturing Cost Structure Analysis of Oseltamivir in 2021
Figure 62. Manufacturing Process Analysis of Oseltamivir
Figure 63. Industry Chain Structure of Oseltamivir
Figure 64. Channels of Distribution
Figure 65. Distributors Profiles
Similar Reports
The United States pneumococcal & meningococcal vaccines market is set to surpass US$ 7.5 Million by the year end of 2025. “United States Pneumococcal & Meningococcal Vaccines Market by Company Profile, Deals Type, Brand Analysis, Share, Key Trends & Opportunities to 2025” presents an in–depth assessment of the United States pneumococcal & meningococcal vaccines market dynamics, opportunitie...
- Publish Date: June 24, 2019
- $1050
The global human immunodeficiency virus (HIV) drugs market size is expected to surpass US$ 30 billion by 2025. “Global Human Immunodeficiency Virus (HIV) Drugs Market 2019 – 2025: Top 22 Drugs Analysis, Key Trends, Players and Forecasts” presents an in-depth assessment of the global human immunodeficiency virus (HIV) drugs market dynamics, opportunities, future roadmap, competitive landscap...
- Publish Date: February 18, 2019
- $1290
The global 50 blockbuster drugs market size is estimated to reach a value of US$ 292 billion by 2025. ‘’Global Blockbuster Drugs Market 2015 - 2025: Top 50 Drugs Analysis, Deal Trends, Players and Forecasts” presents an in-depth assessment of the global blockbuster drugs market dynamics, opportunities, future roadmap, competitive landscape and discusses major trends. The report offers the m...
- Publish Date: December 11, 2018
- $1390
